FDA Approves Yuflyma
FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira JERSEY CITY, N.J.–(BUSINESS WIRE) May 24, 2023 –Celltrion USA today announced that the U.S. Food and Drug […]
Read moreHome »
FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira JERSEY CITY, N.J.–(BUSINESS WIRE) May 24, 2023 –Celltrion USA today announced that the U.S. Food and Drug […]
Read moreCan’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you […]
Read moreAn ounce of prevention … well, you know the rest. In medicine, prevention aims to spot problems before they worsen, affecting both a patient’s health […]
Read moreSACRAMENTO, Calif. — California is still offering free covid testing to uninsured residents even though the federal government ran out of money to pay for […]
Read moreSACRAMENTO, Calif. — Prescription drug costs for California’s massive Medicaid program were draining the state budget, so in 2019 Gov. Gavin Newsom asked the private […]
Read moreWhen Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving […]
Read moreTwo months after Pfizer’s covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. […]
Read moreCan’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you […]
Read moreFederal health officials will likely reject Montana’s request to include work requirements for beneficiaries of its Medicaid expansion program, which insures 100,000 low-income Montana adults, […]
Read morePRINCETON, N.J.–(BUSINESS WIRE) May 27, 2021 — Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 […]
Read more